Sanofi-Aventis Deutschland GmbH
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.
Dosage form: solution for injection
Active substance Dosage insulin glargine 100 IU/ml ATC: A10AE04
-
The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).
Dosage form: solution for injection
Active substance Dosage insulin glargine 100 units/ml lixisenatide 33 mcg/ml ATC: A10AE54
-
The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).
Dosage form: solution for injection
Active substance Dosage insulin glargine 100 units/ml lixisenatide 50 mcg/ml ATC: A10AE54
-
The drug is used to treat various types of cancer, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage docetaxel 20 mg/ml ATC: L01CD02
-
The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 6 years and older.
Dosage form: solution for injection
Active substance Dosage insulin glargine 300 IU/ml ATC: A10AE04
-
The drug is used in dentistry for local anesthesia during standard procedures, such as tooth extraction, preparation of a carious cavity, or preparation of a tooth for a crown.
Dosage form: solution for injection
Active substance Dosage articaine 40 mg/ml epinephrine 0.006 mg/ml ATC: N01BB58
-
The drug is used in dentistry to perform local anesthesia during surgical interventions on teeth, gums, jawbones, or during tooth extractions.
Dosage form: solution for injection
Active substance Dosage articaine 40 mg/ml epinephrine 0.012 mg/ml ATC: N01BB58